Related references
Note: Only part of the references are listed.Course monitoring of membranous nephropathy: Both autoantibodies and podocytes require multidimensional attention
Wenbin Liu et al.
AUTOIMMUNITY REVIEWS (2022)
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
Elion Hoxha et al.
NATURE REVIEWS NEPHROLOGY (2022)
IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies
Inga Koneczny et al.
FRONTIERS IN IMMUNOLOGY (2022)
Kinase inhibition in autoimmunity and inflammation
Ali A. Zarrin et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults
Julie Oniszczuk et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Effect of Mahuang Fuzi and Shenzhuo Decoction on Idiopathic Membranous Nephropathy: A Multicenter, Nonrandomized, Single-Arm Clinical Trial
Zhaocheng Dong et al.
FRONTIERS IN PHARMACOLOGY (2021)
Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy
Roza Motavalli et al.
CYTOKINE (2021)
Membranous nephropathy
Pierre Ronco et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy
Vladimir Tesar et al.
FRONTIERS IN IMMUNOLOGY (2021)
Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature
Ryosuke Saiki et al.
BMC NEPHROLOGY (2021)
Interleukin-17 family members in health and disease
Soo-Hyun Chung et al.
INTERNATIONAL IMMUNOLOGY (2021)
Activation of the acute inflammatory phase response in idiopathic nephrotic syndrome: association with clinicopathological phenotypes and with response to corticosteroids
Neus Roca et al.
CLINICAL KIDNEY JOURNAL (2021)
Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease
Takeshi Tosaki et al.
CEN CASE REPORTS (2021)
Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A
Ran Luo et al.
THERANOSTICS (2021)
Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
Christine Barrett et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease
Rachel S. Simpson et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
Jingyuan Xie et al.
NATURE COMMUNICATIONS (2020)
A comprehensive phenotypic and functional immune analysis unravels circulating anti-PLA2R antibody secreting cells in membranous nephropathy patients
Chiara Cantarelli et al.
Kidney International Reports (2020)
Myeloid-Derived Suppressor Cells Promote the Progression of Primary Membranous Nephropathy by Enhancing Th17 Response
Huimin Li et al.
FRONTIERS IN IMMUNOLOGY (2020)
Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity
Wenbin Liu et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy
Zhaocheng Dong et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses
Marion Cremoni et al.
FRONTIERS IN IMMUNOLOGY (2020)
Novel Therapeutic Approaches in Rheumatoid Arthritis: Role of Janus Kinases Inhibitors
Felice Rivellese et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Low serum C3 level, high neutrophil-lymphocyte-ratio, and high platelet-lymphocyte-ratio all predicted poor long-term renal survivals in biopsy-confirmed idiopathic membranous nephropathy
Shang-Feng Tsai et al.
SCIENTIFIC REPORTS (2019)
The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery
Anne-Els Van de Logt et al.
KIDNEY INTERNATIONAL (2019)
Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
Wenbin Liu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells
Doan C. Nguyen et al.
FRONTIERS IN IMMUNOLOGY (2019)
Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases
Maryam Tahvildari et al.
JOURNAL OF IMMUNOLOGY (2019)
Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy
Giuseppe Stefano Netti et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation
Mael Lateb et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Interleukin (IL-6) Immunotherapy
Toshio Tanaka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
BAFF and APRIL expression as an autoimmune signature of membranous nephropathy
Seung Seok Han et al.
ONCOTARGET (2018)
Glucocorticoids in the Treatment of Glomerular Diseases Pitfalls and Pearls
Claudio Ponticelli et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study
Young Rok Ham et al.
DISEASE MARKERS (2018)
Circulating CD14+CD163+CD206+ M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy
Jie Hou et al.
MEDIATORS OF INFLAMMATION (2018)
Age and Age-Related Diseases: Role of inflammation Triggers and Cytokines
Irene Maeve Rea et al.
FRONTIERS IN IMMUNOLOGY (2018)
A New Classification System for IgG4 Autoantibodies
Inga Koneczny
FRONTIERS IN IMMUNOLOGY (2018)
Clinical implications of pathological features of primary membranous nephropathy
Xiao-dan Zhang et al.
BMC NEPHROLOGY (2018)
Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells
Claudia Burrello et al.
NATURE COMMUNICATIONS (2018)
B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab
Michelle Rosenzwajg et al.
KIDNEY INTERNATIONAL (2017)
Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab
Dagur Ingi Jonsson et al.
NEUROMUSCULAR DISORDERS (2017)
Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathy
Yen-Sung Huang et al.
ONCOTARGET (2017)
Effects of CD20+B-cell infiltration into allografts on kidney transplantation outcomes: a systematic review and meta-analysis
Yingying Lu et al.
ONCOTARGET (2017)
Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
Hua Su et al.
FRONTIERS IN IMMUNOLOGY (2017)
Higher frequencies of circulating ICOS+, IL-21+ T follicular helper cells and plasma cells in patients with new-onset membranous nephropathy
Zhihui Zhang et al.
AUTOIMMUNITY (2017)
Primary Membranous Nephropathy
William G. Couser
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
Shubhasree Banerjee et al.
DRUGS (2017)
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature
D. Roccatello et al.
AUTOIMMUNITY REVIEWS (2016)
JAK inhibition in the treatment of diabetic kidney disease
Frank C. Brosius et al.
DIABETOLOGIA (2016)
Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies
Rufei Lu et al.
JOURNAL OF AUTOIMMUNITY (2016)
Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China
Xin Xu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
BAFF- and APRIL-targeted therapy in systemic autoimmune diseases
Shingo Nakayamada et al.
INFLAMMATION AND REGENERATION (2016)
T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
Dimitra Kalavrizioti et al.
CYTOKINE (2015)
Commentary: IL-4 and IL-13 receptors and signaling
Sarah M. McCormick et al.
CYTOKINE (2015)
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy
Ankit Saxena et al.
CYTOKINE (2015)
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy
Ioannis Parodis et al.
LUPUS SCIENCE & MEDICINE (2015)
Regulation of IL-6-type cytokine responses by MAPKs
Ana P. Costa-Pereira
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
IgG4-related membranous nephropathy with high blood and low urine IgG4/IgG ratio: a case report and review of the literature
Xiao-li Li et al.
CLINICAL RHEUMATOLOGY (2014)
Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function
Yizhi Chen et al.
JOURNAL OF NEPHROLOGY (2014)
Circulating TNF Receptors Are Significant Prognostic Biomarkers for Idiopathic Membranous Nephropathy
Su Mi Lee et al.
PLOS ONE (2014)
Ectopic lymphoid-like structures in infection, cancer and autoimmunity
Costantino Pitzalis et al.
NATURE REVIEWS IMMUNOLOGY (2014)
B-cell-targeted therapies in systemic lupus erythematosus
Vera Sau-Fong Chan et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
IL-10-Producing Lymphocytes in Inflammatory Disease
Yang Yao et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2013)
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses
Willem van de Veen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
Tom A. Barr et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection
Kathryn Brown et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Th17 cells in inflammation
Akihiro Kimura et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
The Influence of Excessive IL-6 Production In Vivo on the Development and Function of Foxp3(+) Regulatory T Cells
Minoru Fujimoto et al.
JOURNAL OF IMMUNOLOGY (2011)
Macrophages in Renal Disease
Yiping Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy
R. Naumovic et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Effect of IL-6 C-572G polymorphism on idiopathic membranous nephropathy risk in a han chinese population
Shih-Yin Chen et al.
RENAL FAILURE (2010)
Signals that influence T follicular helper cell differentiation and function
Michelle A. Linterman et al.
SEMINARS IN IMMUNOPATHOLOGY (2010)
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma
C. K. Oh et al.
EUROPEAN RESPIRATORY REVIEW (2010)
Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study
Sofia Lionaki et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium
Frances Humby et al.
PLOS MEDICINE (2009)
Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations
Gerald J. Prud'homme
LABORATORY INVESTIGATION (2007)
Specific changes in plasma concentrations of matrix metalloproteinase-2 and-9, TIMP-1 and TGF-β1 in patients with distinct types of primary glomerulonephritis
Brigitte Bauvois et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset/occurrence of idiopathic membranous nephropathy
D. Thibaudin et al.
KIDNEY INTERNATIONAL (2007)
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Interleukin-6 and its receptor: from bench to bedside
Juergen Scheller et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2006)
BAFF, APRIL and their receptors: Structure, function and signaling
Claudia Bossen et al.
SEMINARS IN IMMUNOLOGY (2006)
Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory t cells
HH Oberg et al.
INTERNATIONAL IMMUNOLOGY (2006)
Lymphoid neogenesis in chronic inflammatory diseases
F Aloisi et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency
PWG du Buf-Vereijken et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis
C Bantis et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy
A Kuroki et al.
KIDNEY INTERNATIONAL (2005)
Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy
K Masutani et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Predominance of type-2 immune response in idiopathic membranous nephropathy - Cytoplasmic cytokine analysis
K Hirayama et al.
NEPHRON (2002)
IL-4 therapy prevents the development of proteinuria in active heymann nephritis by inhibition of tel cells
ST Spicer et al.
JOURNAL OF IMMUNOLOGY (2001)
Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy
SA Mezzano et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
